The world’s first textbook on ‘3D Printing of Pharmaceuticals’ is launched by UCL

3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine.

Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting.

This text was edited by two leading academics from UCL School of Pharmacy (Professor Abdul Basit and Professor Simon Gaisford), who brought together the leading 3D printing experts in the pharmaceutical field. A number of the contributors also work at UCL School of Pharmacy, including Christine Madla, Sarah Trenfield, Atheer Awad, Pamela Robles Martinez, Fabrizio Fina, Alvaro Goyanes and Jack Firth, as well as external collaborators, who aimed to provide extensive information on an array of 3D printing techniques.

Current printing technologies and their state-of-the-art applications in the pharmaceutical manufacturing supply chain have been reviewed, as well as the discussion of modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals.

To find out more information or to purchase the book, please follow the link: https://www.springer.com/us/book/9783319907543. Free previews of each chapter are also available.

Further information:

Prof Abdul Basit

Prof Simon Gaisford

Media Contact: Sonia Sanchez